GlassScriptPhysician profile
Jeffrey M Marks
NPI 1962897470
$6,440.19
in general payments reported to CMS, 2019-2025
43 companies · $927 in 2025
The $927 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $94.98 · 2021: $749 · 2022: $2,068 · 2023: $1,907 · 2024: $694 · 2025: $927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,598 · Travel and Lodging: $827 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,598.21 |
| Travel and Lodging | $826.75 |
| Education | $103.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,548.05 | 2021-2025 | |
| Conmed Corporation | $1,049.28 | 2022-2023 | Airseal |
| Boston Scientific Corporation | $630.82 | 2020-2025 | Lithovue, Spaceoar Vue System - 10ml |
| Abbvie INC. | $425.18 | 2021-2025 | |
| Intuitive Surgical, INC. | $250.72 | 2022-2024 | Da Vinci Surgical System |
| Teleflex LLC | $222.18 | 2022-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $184.80 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Bayer Healthcare Pharmaceuticals INC. | $170.69 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $154.86 | 2022-2024 | Xiaflex |
| Olympus America INC. | $153.07 | 2022-2025 | Itind System |
| Antares Pharma, INC. | $149.31 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $118.32 | 2024-2025 | Xtandi |
| C. R. Bard, INC. & Subsidiaries | $106.68 | 2023 | Bard Urinary Drainage Bag |
| Swan Valley Medical Incorporated | $105.24 | 2022 | |
| Janssen Biotech, INC. | $102.87 | 2021-2024 | Erleada |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $78.31 | 2022-2025 | Provenge |
| 180 Medical, INC. | $72.86 | 2022-2023 | |
| Myriad Genetic Laboratories, INC. | $67.96 | 2024-2025 | Prolaris |
| Urogen Pharma, INC. | $63.28 | 2024-2025 | |
| Endo USA, INC. | $62.43 | 2024-2025 | Xiaflex |
| Sumitomo Pharma America, INC. | $61.42 | 2023-2025 | Orgovyx |
| Kerecis Limited | $57.15 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Tela Bio, INC. | $55.56 | 2022 | |
| Progenics Pharmaceuticals, INC. | $54.47 | 2022-2023 | Pylarify |
| Pfizer INC. | $46.47 | 2021-2022 | |
| Tolmar, INC. | $40.10 | 2023-2024 | |
| Rochester Medical Corporation | $37.72 | 2022 | |
| Blue Earth Diagnostics | $36.17 | 2021-2025 | Posluma |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Becton, Dickinson and Company | $29.79 | 2023 | Bard Urinary Drainage Bag |
| Angiodynamics, INC. | $28.68 | 2023 | Nanoknife |
| Ambu INC. | $28.13 | 2023 | |
| Myovant Sciences INC. | $24.52 | 2022 | |
| Immunitybio, INC. | $24.20 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $23.96 | 2025 | |
| Axonics, INC. | $22.75 | 2022 | |
| Calyxo, INC. | $18.44 | 2024 | Cvac Aspiration System |
| Azurity Pharmaceuticals, INC. | $17.69 | 2025 | Azmiro |
| Verity Pharmaceuticals INC. | $16.78 | 2025 | Tlando |
| Allergan, INC. | $16.51 | 2022 | |
| Photocure INC | $16.49 | 2023 | Cysview |
| Novo Nordisk INC | $15.98 | 2024 | Rivfloza |
| Steris Corporation | $15.24 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.